Monoxerutin
CARDIOVASCULAR SYSTEM
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Monoxerutin is a drug catalogued in DrugCentral. Recorded indications include Peripheral venous insufficiency.
- Indications: Peripheral venous insufficiency.
- ATC code: C05CA02 (Bioflavonoids).
- Molecular formula: C29H34O17; molecular weight 654.57 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Peripheral venous insufficiency
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
C05CA02 | CARDIOVASCULAR SYSTEM › VASOPROTECTIVES › CAPILLARY STABILIZING AGENTS › Bioflavonoids |
Chemical structure
| Molecular formula | C29H34O17 |
|---|---|
| Molecular weight | 654.57 g/mol |
| CAS number | 23869-24-1 |
| InChIKey | MBHXKZDTQCSVPM-BDAFLREQSA-N |
| PubChem CID | 9852585 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Monoxerutin used for?
DrugCentral lists the following indications for Monoxerutin: Peripheral venous insufficiency.
What is the chemical formula of Monoxerutin?
Monoxerutin has the molecular formula C29H34O17 and a molecular weight of 654.57 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 1835 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL3527416 — compound record and bioactivity
- PubChem CID 9852585 — chemical identifiers
- DrugBank DB13764 — drug record
- FDA UNII EKF7043SBU — substance identity
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.